|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Articles in PresS, published online ahead of print June 11, 2002
Am J Physiol Renal Physiol, 10.1152/ajprenal.00181.2002
Submitted on May 9, 2002
Accepted on June 3, 2002
1 Department of Diabetes, Beckman Research Institute of the City of Hope, Duarte, CA, USA
2 Department of Nephrology, Harbor-UCLA Research and Education Institute, Torrance, CA, USA
3 Molecular Biology Department, Beckman Research Institute of the City of Hope, Duarte, CA, USA
4 Department of Endocrinology, University of Virginia Medical School, Charlottsville, VA, USA
* To whom correspondence should be addressed. E-mail: rnatarajan{at}coh.org.
The lipoxygenase (LO) pathway of arachidonate metabolism and mitogen-activated protein kinases (MAPKs) can mediate cellular growth and angiotensin II (AngII) effects in vascular smooth muscle cells. However, their role in renal mesangial cells is not very clear. AngII treatment of rat mesangial cells (RMC) significantly increased 12-LO mRNA expression and formation of the 12-LO product, 12(S)-hydroxyeicosatetraenoic acid (12(S)-HETE) (p<0.03). AngII-induced [3H]-leucine incorporation was blocked by a LO inhibitor, CDC (p<0.02). Furthermore, 12(S)-HETE, directly induced cellular hypertrophy and FN expression (p<0.01) to a similar extent as AngII. Both AngII and 12(S)-HETE led to the activation of p38MAPK and its target transcription factor, CREB. AngII- and 12(S)-HETE-induced CREB activation and [3H]-leucine incorporation were blocked by the p38MAPK inhibitor, SB202190. Furthermore, a specific molecular inhibitor of rat 12-LO mRNA, namely a novel ribozyme, could attenuate Ang II-induced FN mRNA. Thus, p38MAPK-dependent CREB activation may mediate AngII- and LO product-induced FN expression and cellular growth in RMC. Furthermore, AngII effects may be mediated by the LO pathway. These results suggest a novel interaction between LO and p38MAPK activation in MC matrix synthesis associated with renal complications.
This article has been cited by other articles:
![]() |
Z.-G. Xu, L.-N. Miao, Y.-C. Cui, Y. Jia, H. Yuan, and M. Wu Angiotensin II type 1 receptor expression is increased via 12-lipoxygenase in high glucose-stimulated glomerular cells and type 2 diabetic glomeruli Nephrol. Dial. Transplant., June 1, 2009; 24(6): 1744 - 1752. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Abdel-Rahman, P. M. Abadir, and H. M. Siragy Regulation of renal 12(S)-hydroxyeicosatetraenoic acid in diabetes by angiotensin AT1 and AT2 receptors Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2008; 295(5): R1473 - R1478. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Yuan, L. Lanting, Z.-G. Xu, S.-L. Li, P. Swiderski, S. Putta, M. Jonnalagadda, M. Kato, and R. Natarajan Effects of cholesterol-tagged small interfering RNAs targeting 12/15-lipoxygenase on parameters of diabetic nephropathy in a mouse model of type 1 diabetes Am J Physiol Renal Physiol, August 1, 2008; 295(2): F605 - F617. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z.-G. Xu, H. Yuan, L. Lanting, S.-L. Li, M. Wang, N. Shanmugam, M. Kato, S. G. Adler, M. A. Reddy, and R. Natarajan Products of 12/15-Lipoxygenase Upregulate the Angiotensin II Receptor J. Am. Soc. Nephrol., March 1, 2008; 19(3): 559 - 569. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Jalvy, M.-A. Renault, L. Lam Shang Leen, I. Belloc, A. Reynaud, A.-P. Gadeau, and C. Desgranges CREB Mediates UTP-Directed Arterial Smooth Muscle Cell Migration and Expression of the Chemotactic Protein Osteopontin via Its Interaction with Activator Protein-1 Sites Circ. Res., May 11, 2007; 100(9): 1292 - 1299. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. S. Kang, Y. G. Park, B. K. Kim, S. Y. Han, Y. H. Jee, K. H. Han, M. H. Lee, H. K. Song, D. R. Cha, S. W. Kang, et al. Angiotensin II stimulates the synthesis of vascular endothelial growth factor through the p38 mitogen activated protein kinase pathway in cultured mouse podocytes. J. Mol. Endocrinol., April 1, 2006; 36(2): 377 - 388. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. W. Reinhold, H. Vitzthum, T. Filbeck, K. Wolf, C. Lattas, G. A. J. Riegger, A. Kurtz, and B. K. Kramer Gene expression of 5-, 12-, and 15-lipoxygenases and leukotriene receptors along the rat nephron Am J Physiol Renal Physiol, April 1, 2006; 290(4): F864 - F872. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. R. Preston, N. S. Hill, R. R. Warburton, and B. L. Fanburg Role of 12-lipoxygenase in hypoxia-induced rat pulmonary artery smooth muscle cell proliferation Am J Physiol Lung Cell Mol Physiol, February 1, 2006; 290(2): L367 - L374. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z.-G. Xu, L. Lanting, N. D. Vaziri, Z. Li, L. Sepassi, B. Rodriguez-Iturbe, and R. Natarajan Upregulation of Angiotensin II Type 1 Receptor, Inflammatory Mediators, and Enzymes of Arachidonate Metabolism in Obese Zucker Rat Kidney: Reversal by Angiotensin II Type 1 Receptor Blockade Circulation, April 19, 2005; 111(15): 1962 - 1969. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-S. Kim, Z.-G. Xu, M. A. Reddy, S.-L. Li, L. Lanting, K. Sharma, S. G. Adler, and R. Natarajan Novel Interactions between TGF-{beta}1 Actions and the 12/15-Lipoxygenase Pathway in Mesangial Cells J. Am. Soc. Nephrol., February 1, 2005; 16(2): 352 - 362. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Stambe, R. C. Atkins, G. H. Tesch, T. Masaki, G. F. Schreiner, and D. J. Nikolic-Paterson The Role of p38{alpha} Mitogen-Activated Protein Kinase Activation in Renal Fibrosis J. Am. Soc. Nephrol., February 1, 2004; 15(2): 370 - 379. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Naito, T. Masaki, D. J. Nikolic-Paterson, C. Tanji, N. Yorioka, and N. Kohno Angiotensin II induces thrombospondin-1 production in human mesangial cells via p38 MAPK and JNK: a mechanism for activation of latent TGF-{beta}1 Am J Physiol Renal Physiol, February 1, 2004; 286(2): F278 - F287. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Yiu, X. Zhao, E. W. Inscho, and J. D. Imig 12-Hydroxyeicosatetraenoic acid participates in angiotensin II afferent arteriolar vasoconstriction by activating L-type calcium channels J. Lipid Res., December 1, 2003; 44(12): 2391 - 2399. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Reddy, Y.-S. Kim, L. Lanting, and R. Natarajan Reduced Growth Factor Responses in Vascular Smooth Muscle Cells Derived from 12/15-Lipoxygenase-Deficient Mice Hypertension, June 1, 2003; 41(6): 1294 - 1300. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |